Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Other Working Capital Changes: 2019-2024

Historic Other Working Capital Changes for Day One Biopharmaceuticals (DAWN) over the last 6 years, with Dec 2024 value amounting to $4.8 million.

  • Day One Biopharmaceuticals' Other Working Capital Changes fell 133.22% to -$480,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 73.83%. This contributed to the annual value of $4.8 million for FY2024, which is 44.10% up from last year.
  • Per Day One Biopharmaceuticals' latest filing, its Other Working Capital Changes stood at $4.8 million for FY2024, which was up 44.10% from $3.3 million recorded in FY2023.
  • In the past 5 years, Day One Biopharmaceuticals' Other Working Capital Changes ranged from a high of $4.8 million in FY2024 and a low of $546,000 during FY2022.
  • For the 3-year period, Day One Biopharmaceuticals' Other Working Capital Changes averaged around $2.9 million, with its median value being $3.3 million (2023).
  • As far as peak fluctuations go, Day One Biopharmaceuticals' Other Working Capital Changes spiked by 33,500.00% in 2020, and later plummeted by 85.31% in 2022.
  • Yearly analysis of 5 years shows Day One Biopharmaceuticals' Other Working Capital Changes stood at $1.3 million in 2020, then soared by 178.22% to $3.7 million in 2021, then crashed by 85.31% to $546,000 in 2022, then soared by 508.42% to $3.3 million in 2023, then skyrocketed by 44.10% to $4.8 million in 2024.